Clorox Reports Q3 Fiscal Year 2021 Results, Updates Fiscal Year Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Clorox (CLX) PT Lowered to $195 at Jefferies
May 4, 2021 6:00 AM EDTJefferies analyst Kevin Grundy lowered the price target on Clorox (NYSE: CLX) to $195.00 (from $205.00) while maintaining a Hold rating.
The analyst comments "We trim our FY22-23 EPS ests.... More
Clorox (CLX) Tops Q3 EPS by 14c, Revenue Misses, Guides Below Consensus
April 30, 2021 6:38 AM EDTClorox (NYSE: CLX) reported Q3 EPS of $1.62, $0.14 better than the analyst estimate of $1.48. Revenue for the quarter came in at $1.78 billion versus the consensus estimate of $1.87 billion.
GUIDANCE:
Clorox sees FY2021 EPS of $7.45-$7.65, versus the consensus of $8.35.
10% to 13% sales growth (10% to 13% organic sales growth)$5.94 to $6.14 diluted EPS range (19% to 16% decrease versus year ago)$7.45 to $7.65 adjusted EPS range (1% to 4% increase versus year ago)Excludes the $2.11 loss from the noncash impairment related to the VMS business and the 60-cent one-time noncash gain from the Saudi JV acquisition... More


